维普中文期刊产品整合服务
12篇 您的检索式:作者名="EngelmanJA"
    题名 作者 年代 出处 被引量
1The evolution of phosphati?dylinositol 3 -kinases as regnlators of growth and metabolism显示文摘EngelmanJA LuoJ Cantley LC 2006Nat Rev Genet2006,7,8:1
2MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling显示文摘ENGELMANJA ZEJNULLAHU K MITSUDOMI T 2007Science2007,316,5827:1
3Allelic dilution obscures detection of a biologically significant resistance mutation in EGFR-amplified lung cancer显示文摘EngelmanJA Mukohara T Zejnullahu K 0,,10:1
4MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling显示文摘ENGELMANJA ZEJNULLAHU K MITSUDOMI T 2007Science2007,316,5827:1
5Factors predicting response to EGFR tyrosine kinase inhibitors显示文摘EngelmanJA Janne PA 2005Semin Respir Crit CareMed2005,26,3:1
6Effective use of PI3 K and MEK inhibitors to treat mutant Kras G12D and PIK3CA HI047R murine lung cancers显示文摘EngelmanJA Chen L Tan X 2008Nat Med2008,14,12:1
7MET amplifica- tion leads to gefitinib resistance in lung cancer by activating ERBB3 signaling显示文摘EngelmanJA Zejnullahu K Mitsudomi T 2007Science2007,316,5827:1
8Ceritinib in ALK-rearranged non-small?cell lung cancer显示文摘Shaw AT EngelmanJA 2014N EnglJ Med2014,370,26:1
9MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling显示文摘EngelmanJA Zejnullahu K Mitsudomi T 2007Science2007,316,5827:1
10Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers显示文摘EngelmanJA ChenL TanX 2008Nat Med2008,14,12:1
11Ceritinib in ALK-rearranged non-small?cell lung cancer显示文摘Shaw AT EngelmanJA 2014N EnglJ Med2014,370,26:1
12Breast cancer?associated PIK3CA mutations are oncogenic in mammary epithelial cells显示文摘Isakoff SJ EngelmanJA Irie HY 2005Cancer Res2005,65,10:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费